This study examined whether tenecteplase improves outcomes in patients with acute ischemic stroke caused by non–large vessel blockages (occlusions) and evidence of salvageable brain tissue when given between 4.5 and 24 hours after symptom onset.
JAMA (Journal of the American Medical Association) published a clinical update in Research Highlights on 07 Apr 2026.
The item focuses on Tenecteplase for Acute Non–Large Vessel Occlusion Ischemic Stroke Research Summary.
Review the original article for the full source wording and details.